• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of April 30, 2014

  • Print
  • Share
  • E-mail

Product Detail

Product Description XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
Recall Number D-1250-2014
Classification Class I
Code Info All Lots
Product Distributed Qty 8 bottles
Reason For Recall Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

Event Detail

Event Id 65383
Product Type Drugs
Status Ongoing
Recalling Firm Dolphin Intertrade Corporation
City Miami
State FL
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-05-20
Initial Firm Notification of Consignee or Public E-Mail
Distribution Pattern Nationwide